Tag: EBITDA
Metropolis Healthcare reports 15% growth in core revenue in Q4FY24
The company’s key highlights include a surge in patient volume by 9% and strong B2C revenue growth
Biocon’s biosimilars revenue crosses milestone of US $1 Billion in FY...
The company garnered an overall revenue of Rs 15,621 Crore in FY24, marking a remarkable 35% growth compared to the previous year
Dr Lal PathLabs records revenue of Rs 2,295.8 crore in FY24
The company has posted net profit of Rs 357.7 crores for the Financial Year ended March 31, 2024
Biocon clocks Rs 4,519 crore revenue in Q3 of FY24, earns...
The company revenue in biosimilars went up by 65%; research services up by 9%; EBITDA stood at Rs 1,492 Crore, up 106%; Net Profit at Rs 660 Crore
Merck delivers profitable growth at 12.9% despite challenges during FY 2022
Sales growth was driven by all regions and business sectors, particularly life science
Max Healthcare reports strong growth in Q3
Company's gross revenue stood at INR 1160 Cr, a growth of 6% YoY and 24% QoQ.....................